Cargando…

Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies

Multiple studies have hypothesized parity is associated with pancreatic cancer risk but obtained conflicting results. We conducted a meta-analysis (including a dose-response approach) of current available epidemiologic studies to investigate the association between parity and risk of pancreatic canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Beibei, Zou, Li, Han, Juan, Chen, Wei, Shen, Na, Zhong, Rong, Li, Jiaoyuan, Chen, Xueqin, Liu, Cheng, Shi, Yang, Miao, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060503/
https://www.ncbi.nlm.nih.gov/pubmed/24936955
http://dx.doi.org/10.1038/srep05313
_version_ 1782321382063865856
author Zhu, Beibei
Zou, Li
Han, Juan
Chen, Wei
Shen, Na
Zhong, Rong
Li, Jiaoyuan
Chen, Xueqin
Liu, Cheng
Shi, Yang
Miao, Xiaoping
author_facet Zhu, Beibei
Zou, Li
Han, Juan
Chen, Wei
Shen, Na
Zhong, Rong
Li, Jiaoyuan
Chen, Xueqin
Liu, Cheng
Shi, Yang
Miao, Xiaoping
author_sort Zhu, Beibei
collection PubMed
description Multiple studies have hypothesized parity is associated with pancreatic cancer risk but obtained conflicting results. We conducted a meta-analysis (including a dose-response approach) of current available epidemiologic studies to investigate the association between parity and risk of pancreatic cancer. Ten cohort studies and ten case-control studies including 8205 cases were eligible for inclusion. The combined RR (relative risk) of pancreatic cancer for the parous vs. nulliparous was 0.91 (95% CI, confidence interval = 0.85–0.97, I(2) = 39.0%, P(h) = 0.01). We observed an inverse association between giving birth to two children pancreatic cancer risk with RR of 0.86 (95% CI = 0.80–0.93, I(2) = 8.7%, P(h) = 0.36). And no evidence supported there was non-linear (P = 0.33) or linear relationship (P = 0.14) between number of parity and risk of pancreatic cancer. Findings from this meta-analysis indicate that giving birth to two children has the lowest pancreatic cancer risk, mechanism of this protective effect needs further investigation.
format Online
Article
Text
id pubmed-4060503
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-40605032014-06-18 Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies Zhu, Beibei Zou, Li Han, Juan Chen, Wei Shen, Na Zhong, Rong Li, Jiaoyuan Chen, Xueqin Liu, Cheng Shi, Yang Miao, Xiaoping Sci Rep Article Multiple studies have hypothesized parity is associated with pancreatic cancer risk but obtained conflicting results. We conducted a meta-analysis (including a dose-response approach) of current available epidemiologic studies to investigate the association between parity and risk of pancreatic cancer. Ten cohort studies and ten case-control studies including 8205 cases were eligible for inclusion. The combined RR (relative risk) of pancreatic cancer for the parous vs. nulliparous was 0.91 (95% CI, confidence interval = 0.85–0.97, I(2) = 39.0%, P(h) = 0.01). We observed an inverse association between giving birth to two children pancreatic cancer risk with RR of 0.86 (95% CI = 0.80–0.93, I(2) = 8.7%, P(h) = 0.36). And no evidence supported there was non-linear (P = 0.33) or linear relationship (P = 0.14) between number of parity and risk of pancreatic cancer. Findings from this meta-analysis indicate that giving birth to two children has the lowest pancreatic cancer risk, mechanism of this protective effect needs further investigation. Nature Publishing Group 2014-06-17 /pmc/articles/PMC4060503/ /pubmed/24936955 http://dx.doi.org/10.1038/srep05313 Text en Copyright © 2014, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Article
Zhu, Beibei
Zou, Li
Han, Juan
Chen, Wei
Shen, Na
Zhong, Rong
Li, Jiaoyuan
Chen, Xueqin
Liu, Cheng
Shi, Yang
Miao, Xiaoping
Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies
title Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies
title_full Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies
title_fullStr Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies
title_full_unstemmed Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies
title_short Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies
title_sort parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060503/
https://www.ncbi.nlm.nih.gov/pubmed/24936955
http://dx.doi.org/10.1038/srep05313
work_keys_str_mv AT zhubeibei parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT zouli parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT hanjuan parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT chenwei parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT shenna parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT zhongrong parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT lijiaoyuan parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT chenxueqin parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT liucheng parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT shiyang parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies
AT miaoxiaoping parityandpancreaticcancerriskevidencefromametaanalysisoftwentyepidemiologicstudies